Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine sustainable innovations. Its world-leading solutions transform the way products are designed, produced, and supported. Dassault Systèmes’ collaborative solutions foster social innovation, expanding possibilities for the virtual world to improve the real world. The group brings value to over 220,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit https://www.3ds.com/
Our portfolio is comprised of 3D modeling applications, simulation applications creating virtual twins of products or production systems, social and collaborative applications, and information intelligence applications. https://www.3ds.com/products-services/
We serve 3 segments within LS industry: Biopharmas, Medtech & what we call Patient care, which includes Healthcare providers. For that segment, we are currently focusing on content. Our life sciences strategy is based on the kinds of products our clients create. Regarding life sciences companies (biopharma & med dev), those companies design, develop and bring to market therapeutics solutions (products) which are used to prevent, diagnose and treat disease. Since a few years they have also been developing digital therapeutics… on which there has been debate for the precise definition for this new technology category but the Digital Therapeutics Alliance, a consortium of industry stakeholders, has proposed the following definition: “Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease ”
